Harmol hydrochloride monohydrate
CAS: 40580-83-4
Ref. 3D-BH175460
| 1g | 493.00 € | ||
| 5g | 1,788.00 € | ||
| 10g | 3,219.00 € | ||
| 2550mg | 1,014.00 € |
Product Information
- 1-Methyl-9H-pyrido[3,4-b]indol-7-ol hydrochloride monohydrate
- 1-Methyl-Beta-Carbolin-7-Ol Hydrochloride Monohydrate
- 1-methyl-2,9-dihydro-7H-beta-carbolin-7-one hydrochloride hydrate
- 9H-Pyrido[3,4-b]indol-7-ol, 1-methyl-, hydrochloride (1:1)
- 9H-Pyrido[3,4-b]indol-7-ol, 1-methyl-, monohydrochloride
- Harmol hydrochloride
- Harmol hydrochloride dihydrate
- NSC 640470
Harmol hydrochloride monohydrate (HHLM) is an agent that is used for the treatment of lysosomal storage diseases. It is a precursor to the harmol glucuronide, which can be converted back to harmol by β-glucuronidase in the gut. Harmol hydrochloride monohydrate has been shown to activate pluripotent stem cells and autophagy, resulting in increased cell survival. This drug also increases the expression of gangliosides and enhances filtration rates in kidney cells. Harmol hydrochloride monohydrate has also been shown to increase β-glucuronidase activity, leading to a decrease in blood levels of harmine hydrochloride.
Chemical properties
Technical inquiry about: 3D-BH175460 Harmol hydrochloride monohydrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
